VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
about
Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell BiologyConnecting the speckles: Splicing kinases and their role in tumorigenesis and treatment responseSplice isoforms as therapeutic targets for colorectal cancerThe anti-angiogenic isoforms of VEGF in health and disease.Programmed translational readthrough generates antiangiogenic VEGF-AxVEGF-A165b is cytoprotective and antiangiogenic in the retinaDo anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary taleDetection of VEGF-A(xxx)b isoforms in human tissuesNeutralization of vascular endothelial growth factor antiangiogenic isoforms or administration of proangiogenic isoforms stimulates vascular development in the rat testis.Abnormal histone methylation is responsible for increased vascular endothelial growth factor 165a secretion from airway smooth muscle cells in asthma.Association between VEGF splice isoforms and progression-free survival in metastatic colorectal cancer patients treated with bevacizumab.Angiogenesis and breast cancer.Assessing the in vivo efficacy of biologic antiangiogenic therapies.Mechanisms that influence tumour response to VEGF-pathway inhibitors.Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update.New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation.Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer.WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.Effects of exogenous VEGF(165)b on invasion and migration of human lung adenocarcinoma A549 cells.VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A.Bevacizumab and intraocular tumors: an intriguing paradox.Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-Axxxb) in colorectal cancer patients predicts tumour VEGF-A ratios
P2860
Q26798154-BCA1948D-93A1-40B6-841C-440FA7C7C99EQ26824298-9FE3CE5B-DC6F-418E-80BF-35A8442E5DFCQ27006500-9B162D45-77FF-4BE4-AAEE-48B768D30F96Q33901839-B7F3A5CB-5A91-4CCC-911A-9742E482BC80Q33959462-182DCD56-322A-4029-A69D-08E958D7ECBBQ34022623-A1E70953-7229-4343-A257-ED0F991DFA82Q34261539-E24A27A6-A874-4F0C-8221-BAB09F8525C8Q34918179-CCB4707F-5732-4824-82B4-9D5406953BC2Q35064895-65848657-9B33-476E-83C9-1F558B563F37Q36086891-536C5861-11A9-4416-AE68-229B77A2DFCCQ36700844-EE309451-0D51-461B-8A49-2C0AD6818B9BQ37800804-81A03F8C-A768-44B8-962D-921D23A8D666Q38051013-DAD1277B-3BF9-463B-A3D6-AF190925B568Q38268452-76F8FFD0-658F-4881-8F68-F5293A658C73Q38317180-3C97FBFB-067E-4C8A-BD19-1B894A5F1F8CQ38319139-78907E7E-1785-402C-B8D7-9EC37B70F109Q39036253-F39CD420-EBF9-4922-A676-5D14315E23EDQ39427761-5C17999B-57CB-4666-A481-D8CB356F232BQ39450742-624E6E3D-C7BE-4A87-8A82-27F8EC8FD9F2Q39613701-06AE6989-B33B-4B84-97DB-9E34975ABF19Q42222703-2FC3A0AE-60B2-4688-838A-A58E36626C30Q42427504-4FF2D799-F8D4-4407-96F0-8DC7C17631E1
P2860
VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
VEGF(121)b, a new member of th ...... tion and tumour growth in vivo
@en
VEGF(121)b, a new member of th ...... ion and tumour growth in vivo.
@nl
type
label
VEGF(121)b, a new member of th ...... tion and tumour growth in vivo
@en
VEGF(121)b, a new member of th ...... ion and tumour growth in vivo.
@nl
prefLabel
VEGF(121)b, a new member of th ...... tion and tumour growth in vivo
@en
VEGF(121)b, a new member of th ...... ion and tumour growth in vivo.
@nl
P2093
P2860
P356
P1476
VEGF(121)b, a new member of th ...... tion and tumour growth in vivo
@en
P2093
A J Churchill
E R Wheatley
E S Rennel
S J Harper
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605249
P407
P577
2009-08-25T00:00:00Z